Diffusion Study on Patients With Osteosarcoma

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-09-30

Study Completion Date

2019-06-07

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is to assess the accuracy of dynamic contrast enhanced and diffusion-weighted MR Imaging in evaluating response to chemotherapy in osteosarcoma.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Modern Hybrid Imaging in Patients With OSCC

NCT04280159

Neoplasm

COMPLETED

PET-CT vs DWI-MRI in Response Evaluation in Esophageal Cancer

NCT02839109

Esophageal Tumor

COMPLETED

Dose Efficiency of Modern CT Scanners in Oncologic Scans

NCT04989192

Neoplasms Neoplasm Metastasis Metastatic Cancer

UNKNOWN NA

Early Therapy Response Monitoring in Melanoma Patients Using PET/MRI

NCT03132090

Malignant Melanoma Stage IV

UNKNOWN NA

Myosteatosis in Oeso-gastric Cancer: Clinical Impacts

NCT06419244

Esophageal Cancer Gastric Cancer Myopenia +1 more

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Dynamic contrast-enhanced and diffusion-weighted magnetic resonance imaging have the potential to measure early cellular and vascular changes that occur in response to chemotherapy and could therefore be early predictors of therapeutic response.

Aim of our study is to assess the accuracy of dynamic contrast enhanced and diffusion-weighted MR imaging in evaluating response to chemotherapy during the preoperative treatment of osteosarcoma. Patients will undergo dynamic contrast-enhanced and diffusion-weighted magnetic resonance imaging before, during and after chemotherapy.

Our long-term goal is to use these imaging techniques to develop non-invasive methodologies that would be better predictors of tumor response than the current clinical standard and earlier predictors than histological evaluation of the whole tumor.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Osteosarcoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Osteosarcoma patients

Patients with an histologically proven osteosarcoma will be entered into the study.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Histologically confirmed diagnosis of osteosarcoma of all entities
* Written informed consent of patient

Exclusion Criteria

* No written informed consent
* Contraindications to MRI (pacemaker, aneurysm clip, mechanical and/or electrical device or metallic fragment, severe claustrophobia)
* Severe, active co-morbidity
* Major medical illnesses or psychiatric impairments

Eligible Sex

ALL

Accepts Healthy Volunteers

No